Two monoclonal antibody drugs will be used to treat Ebola patients in the Democratic Republic of Congo (DRC) following results of a successful nine-month trial. Over 90% patients who had low levels of the infection survived when treated early with REGN-EB3 or mAb114, according to preliminary data gathered from the trial of 681 patients. The trial
As part of the new £13 million Cancer Research UK Convergence Science Centre at The Institute of Cancer Research, scientists are “re-imagining ultrasound technology to develop a treatment that can liquefy cancer cells in the body using microscopic bubbles” Cancer Research UK has announced the development of the new treatment that doesn’t require invasive surgery, in
A new test which tests for genetic weaknesses in repairing DNA can pick out prostate cancer patients who could benefit from a ‘search-and-destroy’ type medicine. Targeted nuclear medicine, which is part of an emerging class of drugs, is made up of a radioactive particle that can kill cells attached to a ‘homing device’ to seek
